pegnivacogin   Click here for help

GtoPdb Ligand ID: 14733

Synonyms: RB-006 | RB006
Compound class: Nucleic acid
Comment: Pegnivacogin (RB006) is a coagulation factor IXa inhibiting RNA aptamer. Its anticoagulant effects are reversed by the complementary ASO anivamersen. The nucleotides are chemically modified (2'-O-methylnucleotides/2'-MOE and 2'-deoxy-2'-fluoronucleotide/2'-F monomers), with a standard phosphate backbone. PEG is conjugated at the 3' R position in the sequence provided in the pegnivacogin INN record.
No information available.
Summary of Clinical Use Click here for help
The pegnivacogin/anivamersen system (also described as the REG1 system) was progressed to clinical trials, primarily to evaluate its suitability for application in the percutaneous coronary intervention (PCI) setting. The phase 3 REGULATE-PCI trial was halted (by the FDA) due to severe allergic (anaphylactic) reactions observed in trial participants, and enrollment was suspended in mid-2014. Thsi led to termination of REG1 development.